GlaxoSmithKline (GSK)

Add to Watchlists

Create an Alert

40.66 +0.09 +0.21% NYSE Sep 25, 16:58 Delayed 2m USD

GlaxoSmithKline News

Wire

Headline

Time (ET)
Yahoo

UPDATE 2-FDA declines to approve J&J arthritis drug sirukumab

09/25 10:25
MT Newswires

ADR Top % Movers Pre-Bell

09/25 08:32
PR Newswire

Lithium X Expands Brine Field and Establishes Favourable Well Field Conditions

09/25 08:00
Yahoo

Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update

09/22 08:42
MT Newswires

ADR Top % Movers Pre-Bell

09/22 08:40
SA Breaking News

FDA's Woodcock says clinical trials system "broken"

09/21 16:18
Yahoo

Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III

09/21 09:44
Yahoo

How GlaxoSmithKline (GSK) Stock Stands Out in a Strong Industry

09/21 08:33
MT Newswires

ADR Top % Movers Pre-Bell

09/21 08:19
MT Newswires

Theravance Biopharma Says GlaxoSmithKline-Innoviva Study of Trelegy Ellipta For COPD Met Primary Endpoint

09/21 07:49
Yahoo

Is GlaxoSmithKline plc (GSK) a Suitable Value Stock?

09/20 09:40
MT Newswires

ADR Top % Movers Pre-Bell

09/20 08:38
MT Newswires

Pre-Market Briefing: US Equities Futures Tread Water Ahead of Federal Reserve's Policy, Outlook Announcement

09/20 04:59
MT Newswires

Innoviva, GlaxoSmithKline Says Phase 3 Study on COPD Drug Meets Primary Endpoint

09/20 04:34
Yahoo

GSK's new triple lung drug beats other modern inhalers in study

09/20 03:17
Business Wire

GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing Single Inhaler Triple Therapy Trelegy Ellipta Reduced COPD Exacerbations

09/20 02:00
Yahoo

FDA OKs Glaxo's inhaler, first one to combine 3 medicines

09/19 16:40
Yahoo

Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD

09/19 15:05
Yahoo

[$$] Andrew Witty jumps into biotech venture capital

09/19 13:26
MT Newswires

Theravance Says FDA OKs Single Inhaler Therapy for COPD Patients

09/19 12:05

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.